Solitaire Platinum Revascularization Device
Clot Retrieval Thrombectomy for Acute Ischemic Stroke
Clot Retrieval Thrombectomy for Acute Ischemic Stroke
The Solitaire™ Platinum revascularization device, featuring Parametric™ design, a unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO).
In fact, the Solitaire device is indicated to reduce stroke-related disability by showing nearly 70% relative improvement in functional outcomes at 90 days in patients suffering a large vessel occlusion.1
The Solitaire Platinum clot retrieval thrombectomy device is comprised of a nitinol scaffolding design attached to a pushwire. The Solitaire Platinum device is designed to be delivered through a micro catheter, deployed across a clot, and removed along with the clot to enable revascularization of the occluded intracranial vessel.
One of the key features that makes the Solitaire device effective is our unique Parametric™ overlapping stent design. The Solitaire Platinum devices are enhanced with distinctive, evenly spaced platinum markers to provide improved visualization for accurate alignment and clot retrieval.2
Together, this powerful combination of features gives greater confidence during interventional stroke procedures.
Visualize optimal working length of the Solitaire Platinum device for accurate stent alignment.2
Visualize both expansion and compression of the Solitaire Platinum device upon deployment with unique, evenly spaced Platinum markers for real-time procedural feedback.2
Visualize stent behavior during retrieval for optimal revascularization and clot capture success.
Our unique3,4 overlapping design allows the thrombectomy device to expand in larger vessels and compress in smaller vessels during deployment and clot retrieval, all while:
†6mm devices are recommended for use in vessels with a diameter of 3.0 - 5.5mm. Bench testing has been performed to demonstrate the overlapping design of the device that occurs while constrained in vessels with differing diameters.
The Solitaire Platinum family has the options needed for the range of clot types encountered during interventional stroke procedures.
The 6x40 length device simplifies placement with proximal ophthalmic alignment, providing complete visualization and coverage from M2 to ICA.6, 7
Clinical studies prove the Solitaire thrombectomy device reduces stroke-related disability in patients suffering large vessel acute ischemic stroke (AIS) following IV t PA.8-12 Learn more.
See the Neurovascular Product Catalog for information about these related products.
Solitaire Revascularization Device Instructions for Use
This technical manual includes indications, warnings, precautions, product specifications, instructions, and clinical study summary. Find in the product labeling supplied with each device or call Medtronic at 800-961-9055.
Download the model specifications sheet to use as a quick-reference guide for the Solitaire Platinum product details.
The Solitaire™ Platinum Revascularization Device is indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received intravenous tissue plasminogen activator (IV t-PA). Endovascular therapy with the device should be started within 6 hours of symptom onset.
The Solitaire™ Platinum Revascularization Device is indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment.
Cello is a trademark of and is manufactured by Fuji Systems Corporation.
71011-001 Rev. 06/17
Medtronic Internal Report TR-NV12692
Medtronic Internal Report FD2815
Medtronic Internal Report FD2601
Medtronic Internal Report TR-NV13807 Rev A
Pai S.B., et, al. Microsurgical Anatomy of the Middle Cerebral Artery. Neurology India. June 2005. Vol 53. Issue 2. Keshelava G. et, al. Surgical anatomy of petrous part of the internal carotid artery. Neuroanatomy (2009) 8: 46–48
Umansky, F. et al. Microsurgical anatomy of the proximal segments of the middle cerebral artery. J. Neurosurg 61:458-467, 1984
SWIFT PRIME - Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t‑PA vs. t‑PA alone in stroke. N. Engl. J. Med. Jun 11 2015; 372(24):2285-2295.
EXTEND -IA- Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. Mar 12 2015; 372(11):1009-1018.
ESCAPE - Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N. Engl. J. Med. Mar 12 2015; 372(11):1019-1030.
REVASCAT - Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N. Engl. J. Med. Jun 11 2015; 372(24):2296-2306.
MR CLEAN - Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. Jan 1 2015; 372(1):11-20.